Explore comprehensive CDMO services offered by Kenox Pharmaceuticals Inc, supporting end-to-end Anlaytical Testing, Clinical Studies, Drug Development and Manufacturing. Kenox Pharmaceuticals Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A
Description: Kenox Pharmaceuticals is a New Jersey-based Contract Development and Manufacturing Organization (CDMO) (CDMO) established in 2018, specializing in the design, development, manufacturing, and testing of innovative aerosol-based drug delivery systems for inhalation, nasal, and ophthalmic applications. They provide end-to-end services from early-stage research to clinical manufacturing for both sterile and non-sterile combination products, utilizing expertise in technologies like soft mist inhalers (SMIs), pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and nebulizers. Kenox provides end-to-end services for orally inhaled and nasal drug products (OINDPs), supporting early-stage R&D, formulation, compounding, GMP fill-finish, and testing—enabling seamless transition from development to clinical manufacture, especially for Phase I and II trials. The company is recognized for its scientific expertise, flexibility, and customer-focused approach, serving clients in the U.S. and globally. - Show More
